Navigation Links
Study: Antidepressant Use in Pregnancy May Not Affect Baby's Growth
Date:3/20/2013

WEDNESDAY, March 20 (HealthDay News) -- Taking antidepressants during pregnancy does not have an impact on an infant's growth during the first year of life, a new study says.

Previous research suggested that depression during pregnancy could slow infant growth, but there were concerns that prescribing antidepressants to pregnant women might also hinder a baby's physical development.

In this study, Northwestern University researchers found that infants born to mothers who took selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy had a similar weight, length and head circumference over the first year as babies born to mothers who did not have depression and did not take antidepressants during pregnancy.

The infants whose mothers took antidepressants were shorter at birth, but that difference vanished by the time they were 2 weeks old, the study authors reported.

The investigators also found that the growth of infants born to depressed women who did not take SSRIs was similar to infants in the general population.

The study was released online March 20 in advance of publication in an upcoming print issue of the American Journal of Psychiatry.

"Most women want to know about the effect of their depressive illness or the medication they take during pregnancy not only on the infant at birth, but also on the baby's longer-term growth and development," lead author Dr. Katherine Wisner said in a university news release. "This information may help women balance the risks and benefits of continuing their antidepressant treatment during pregnancy."

Depression can harm both a mother's and infant's health, noted Wisner, director of Northwestern's Asher Center for the Study and Treatment of Depressive Disorders, and a professor of psychiatry and behavioral sciences and of obstetrics and gynecology at Northwestern University Feinberg School of Medicine.

Depression in mothers is associated with premature birth and low infant birth weight, which increases the child's risk of heart disease. Depression also affects the mother's appetite, nutrition and prenatal care, and is associated with increased alcohol and drug use, Wisner said.

More information

The U.S. Office on Women's Health has more about pregnancy and depression.

-- Robert Preidt

SOURCE: Northwestern University, news release, March 20, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UK study: Epigenetic changes play a key role in development of chemo resistance in BCa
2. New study: Incidence and mortality of PCa after termination of PSA-based screening
3. Study: Smoking Increases HPV Risks; polyDNA Recommends Gene-Eden-VIR Against HPV
4. Omega XL Reports New Independent Study: Omega-3s Can Boost Children’s IQ
5. Study: 15% of Children Ages 10 - 14 Consider Using Steroids; polyDNA Recommends Muxscle for Safe Muscle Building
6. Study: Dynamic new software improves care of aging brain
7. Bel Marra Health Reports on a New Study: Female Obesity Could Be Due to Less Participation in Household Tasks
8. Study: Steroid Abuse in Teens is Increasing; polyDNA Recommends Muxscle for Safe Muscle Building
9. Study: Catheter-based varicose vein treatments more cost-effective
10. Penn study: Financial incentives affect prostate cancer treatment patterns
11. Study: Mega Vitamins Wont Help After Heart Attack, Chelation Treatment Might
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study: Antidepressant Use in Pregnancy May Not Affect Baby's Growth
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... NJ (PRWEB) , ... January 18, 2017 , ... ... care communications company, launched a new website for its Center for Biosimilars, announced ... will include the latest developments in the field of biosimilars through thought leader ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress ... dentists to choose the best drug option for each patient. Dentists have several general ... better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Iowa , Jan. 18, 2017   ... that subsidiary Caretta Therapeutics plans, in the second ... Venodol, a topical roll-on intended to provide relief ... opioid and steroidal analgesics. It was developed under ... to commercialize products derived from snake venom. ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... Jan. 17, 2017  With an annual growth ranging from 6% to 10%, ... SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the ... CPhI SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
Breaking Medicine Technology: